依沙吖啶联合应用米非司酮终止36例中晚期瘢痕子宫妊娠患者的临床观察

Ethacridine combined use of Miseprinstore tablets termination of 36 cases of uterine cicatricial pregnancy in patients with advanced clinical observation

目的:探讨用乳酸依沙吖啶(即利凡诺)联合米非司酮终止瘢痕子宫中晚期妊娠的有效性及安全性。方法:选择中晚孕身体健康、自愿要求终止妊娠瘢痕子宫患者36例为观察组,顿服米非司酮150 mg同时行羊膜腔内注射利凡诺100 mg;对照组单纯行羊膜腔内注射利凡诺100 mg引产。结果:观察组与对照组引产有效率、总时间、并发症相比差异有统计学意义。结论:米非司酮联合利凡诺终止瘢痕子宫中晚期妊娠明显增加了手术的安全性和有效性,缩短了引产总时间。

Objective：To explore the efficiency and safety of mifeprinstone combining ethacridine in terminating mid-term and terminal gestation with cicatricial uterus. Method： 36 healthy case of mid-term and terminal pregnant patients with cicatricial uterus were observed as volunteer. 150mg of miseprinstone was taken at a draught and lOOmg of ethacridine was injected in the cavity of amnion at the same time. Patients in control group received injection of lOOmg ethacridine in the cavity of amnion. Result：Comparing the observing group and the constrasting group, the efficiency, total time of inducing delivery and complications have significant differences. Conclusion： Miseprinstone combining ethacridine in terminating mid-term and terminal gestation with cicatricial uterus can enhance the safety and efficiency of the operation and shorten the total time of inducing delivery.